InnoCare Pharma Ltd
HKEX:9969
Income Statement
Earnings Waterfall
InnoCare Pharma Ltd
Revenue
|
625.4m
CNY
|
Cost of Revenue
|
-143.4m
CNY
|
Gross Profit
|
482m
CNY
|
Operating Expenses
|
-1.2B
CNY
|
Operating Income
|
-730.9m
CNY
|
Other Expenses
|
-155.7m
CNY
|
Net Income
|
-886.6m
CNY
|
Income Statement
InnoCare Pharma Ltd
Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|
Revenue | ||||
Revenue |
1
N/A
|
1 043
+76 390%
|
625
-40%
|
|
Gross Profit | ||||
Cost of Revenue |
0
|
(66)
|
(143)
|
|
Gross Profit |
1
N/A
|
977
+71 574%
|
482
-51%
|
|
Operating Income | ||||
Operating Expenses |
(496)
|
(1 143)
|
(1 213)
|
|
Selling, General & Administrative |
(152)
|
(430)
|
(602)
|
|
Research & Development |
(392)
|
(700)
|
(596)
|
|
Depreciation & Amortization |
(39)
|
(42)
|
(71)
|
|
Other Operating Expenses |
88
|
29
|
56
|
|
Operating Income |
(494)
N/A
|
(166)
+66%
|
(731)
-341%
|
|
Pre-Tax Income | ||||
Interest Income Expense |
104
|
144
|
(162)
|
|
Non-Reccuring Items |
0
|
(0)
|
0
|
|
Total Other Income |
(1)
|
1
|
(1)
|
|
Pre-Tax Income |
(392)
N/A
|
(20)
+95%
|
(894)
-4 342%
|
|
Net Income | ||||
Tax Provision |
0
|
(47)
|
0
|
|
Income from Continuing Operations |
(392)
|
(67)
|
(894)
|
|
Income to Minority Interest |
0
|
2
|
7
|
|
Net Income (Common) |
(391)
N/A
|
(65)
+84%
|
(887)
-1 274%
|
|
EPS (Diluted) |
-0.22
N/A
|
-0.04
+82%
|
-0.6
-1 400%
|